Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

[Good Practice Data Linkage].

March S, Andrich S, Drepper J, Horenkamp-Sonntag D, Icks A, Ihle P, Kieschke J, Kollhorst B, Maier B, Meyer I, Müller G, Ohlmeier C, Peschke D, Richter A, Rosenbusch ML, Scholten N, Schulz M, Stallmann C, Swart E, Wobbe-Ribinski S, Wolter A, Zeidler J, Hoffmann F.

Gesundheitswesen. 2019 Aug;81(8-09):636-650. doi: 10.1055/a-0962-9933. Epub 2019 Aug 8. German.

2.

RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial.

Doener F, Hong HS, Meyer I, Tadjalli-Mehr K, Daehling A, Heidenreich R, Koch SD, Fotin-Mleczek M, Gnad-Vogt U.

Vaccine. 2019 Mar 22;37(13):1819-1826. doi: 10.1016/j.vaccine.2019.02.024. Epub 2019 Feb 21.

3.

Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial.

Sesay S, Brzostek J, Meyer I, Donazzolo Y, Leroux-Roels G, Rouzier R, Astruc B, Szymanski H, Toursarkissian N, Vandermeulen C, Kowalska E, Van Damme P, Salamand C, Pepin S.

Hum Vaccin Immunother. 2018 Mar 4;14(3):596-608. doi: 10.1080/21645515.2017.1384106. Epub 2017 Nov 27.

4.

Changes in levels of biomarkers of exposure and biological effect in a controlled study of smokers switched from conventional cigarettes to reduced-toxicant-prototype cigarettes.

Shepperd CJ, Newland N, Eldridge A, Haswell L, Lowe F, Papadopoulou E, Camacho O, Proctor CJ, Graff D, Meyer I.

Regul Toxicol Pharmacol. 2015 Jul;72(2):273-91. doi: 10.1016/j.yrtph.2015.04.016. Epub 2015 May 10.

5.

Reference change values to assess changes in concentrations of biomarkers of exposure in individuals participating in a cigarette-switching study.

Camacho OM, Shepperd CJ, Eldridge A, Meyer I, Proctor CJ.

Clin Chem Lab Med. 2014 Mar;52(3):399-411. doi: 10.1515/cclm-2013-0581.

PMID:
24114919
7.

Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men.

Berge K, Piscitelli F, Hoem N, Silvestri C, Meyer I, Banni S, Di Marzo V.

Lipids Health Dis. 2013 May 27;12:78. doi: 10.1186/1476-511X-12-78.

8.

Changes in levels of biomarkers of exposure observed in a controlled study of smokers switched from conventional to reduced toxicant prototype cigarettes.

Shepperd CJ, Eldridge A, Camacho OM, McAdam K, Proctor CJ, Meyer I.

Regul Toxicol Pharmacol. 2013 Jun;66(1):147-62. doi: 10.1016/j.yrtph.2013.02.007. Epub 2013 Mar 25. Erratum in: Regul Toxicol Pharmacol. 2013 Dec;67(3):536.

9.

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age.

Halperin SA, Ward B, Cooper C, Predy G, Diaz-Mitoma F, Dionne M, Embree J, McGeer A, Zickler P, Moltz KH, Martz R, Meyer I, McNeil S, Langley JM, Martins E, Heyward WL, Martin JT.

Vaccine. 2012 Mar 28;30(15):2556-63. doi: 10.1016/j.vaccine.2012.01.087. Epub 2012 Feb 9.

PMID:
22326642
10.

A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction.

Ostenfeld T, Price J, Albanese M, Bullman J, Guillard F, Meyer I, Leeson R, Costantin C, Ziviani L, Nocini PF, Milleri S.

Clin J Pain. 2011 Oct;27(8):668-76. doi: 10.1097/AJP.0b013e318219799a.

PMID:
21540741
11.

Availability and usage of ICT applications among European primary care physicians.

Meyer I, Hüsing T, Dobrev A, Korte W, Artmann J, Stroetmann K.

Stud Health Technol Inform. 2009;143:142-6.

PMID:
19380928
12.

Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly.

de Bruijn I, Meyer I, Gerez L, Nauta J, Giezeman K, Palache B.

Vaccine. 2007 Dec 21;26(1):119-27. Epub 2007 Nov 12.

PMID:
18063446
13.

Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin.

Kosoglou T, Statkevich P, Meyer I, Cutler DL, Musiol B, Yang B, Zhu Y, Maxwell SE, Veltri EP.

Curr Med Res Opin. 2004 Jun;20(6):955-65.

PMID:
15200755
14.

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.

Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra VK, Affrime MB.

Br J Clin Pharmacol. 2002 Sep;54(3):309-19.

Supplemental Content

Loading ...
Support Center